pharmaceutical investing Clearside Biomedical Announces Fourth Quarter 2017 Financial Results and Provides Corporate Update
pharmaceutical investing Tetraphase Pharmaceuticals Reports Fourth Quarter and Full-Year 2017 Financial Results
pharmaceutical investing Catalyst Biosciences Reports Fourth Quarter and Full-Year 2017 Operating & Financial Results
copper investing Project Update: Key Progress Milestones at Pumpkin Hollow Undergound Mine and Open Pit Project
industrial metals investing HPQ Silicon Reports 1,900 % Increase In Total Mass Of Silicon Metal Produced By Gen2 PUREVAP Versus Baseline Gen1 Result
pharmaceutical investing BeiGene Initiates Global Phase 3 Trial of Anti-PD-1 Antibody Tislelizumab in Patients with Esophageal Squamous Cell Carcinoma
copper investing Turquoise Hill: Oyu Tolgoi Marks Early Development Milestone with Completion of Shaft 2 Sinking
Apex Extends Trinity Zone 200 m with 3.55% REO over 116.0 m and 2.35% over 171.5 m in Western Step-out Drilling at Rift
Goldera Expands High-Grade E1 Gold Discovery with Two New Parallel Structures Ahead of Planned Q4 Drilling at Egan Gold Project
Oreterra CEO Letter to Shareholders Provides Forward Guidance on Trek South Drill Results in Advance of Assays
